Licensing & patents
OGT has over 20 patent families covering a range of technologies. OGT actively out-licences certain technologies and in particular operates an open licensing policy for the company’s fundamental microarray technology. OGT also has an interest in in-licensing technologies in the general area of genomic analysis and biomarker discovery.
The intellectual property (IP) portfolio of OGT encompasses a wide range of techniques and technologies and includes:
- DNA and protein microarray technology
- Chemistry for attaching oligonucleotides to surfaces
- Hybridisation and chain extension technologies for sequence determination
- Scanning technology
Post-licensing relationship management forms a key component of the licensing strategy and anyone interested in either the out- or in-licensing opportunities are invited to contact our Licensing and Patents team.